B.Brilliant Revelation Comparision Study

Recruiting now

Conditions studied: Breast Cancer Screening

In brief

This is an observational study to evaluate the MAMMOMAT B.brilliant system. All diagnostic decisions are made by the treating radiologist based upon standard of care clinical imaging acquired on FDA approved devices

Key facts

Study ID

NCT07067788

Run by

University of Pennsylvania

People needed

100

Starts

2025-12-15

Expected to finish

2027-01-30

Last updated by the study team

2026-04-24

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Participants will be ≥ 18 years of age.
• Participants will be females (sex assigned at birth).
• Participants will be presenting for clinical diagnostic mammography with suspicious calcifications or calcifications associated with other lesion types
• Participants must be informed of the investigational nature of this study and be willing to provide written informed consent and participate in this study in accordance with institutional and federal guidelines prior to study-specific procedures.

You may not qualify if…

• Females who are breast-feeding will not be eligible for this study
• Pregnant women will not be included. All females of childbearing potential must attest that they are not pregnant.
• Inability to tolerate imaging procedures in the opinion of an investigator or treating physician.
• Any current medical condition, illness, or disorder, as assessed by medical record review and/or self-reported, that is considered by a physician investigator to be a condition that could compromise participant safety or successful participation in the study.

Where it is running

• Pennsylvania Hospital, Center for Breast Imaging — Philadelphia, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.